Eveline Otte Im Kampe

3PUBLICATIONS
18CO-AUTHORS
Cross-sectional analysisCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 24, 2026
Economic Burden of Post-COVID Syndrome in Germany Between 2021 and 2025: A Statutory Health Insurance Claims Data Analysis.

|Nov 01, 2025
Epidemiology, treatment patterns and effectiveness of adherence to Bacillus Calmette-Guérin therapy in intermediate and high-risk non-muscle-invasive bladder cancer patients: a retrospective cohort analysis using German health claims data.

Jaime Luna, Eveline Otte Im Kampe, Heja Aga-Barfknecht

|Jul 25, 2025
Economic evaluation of oral Nirmatrelvir/ritonavir versus best supportive care in patients at high risk for progression to severe COVID-19 in Germany: a cost-effectiveness analysis.

Constanze Schmalhofer, Eveline Otte Im Kampe, Dirk Eheberg

Pageof 1

Frequent Collaborators

3 joint publications

Agnes Kisser

2 joint publications

Emma Fröling

1 joint publications

Martina Maier

1 joint publications

Jaime Luna